Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

ALK-positive Non-small Cell Lung Cancer × lorlatinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Recurrence 1 Neuroblastoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Ganglioneuroblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Astrocytoma 1 Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer 1 Advanced Non-Small Cell Lung Cancer 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡